Imaging neoadjuvant therapy response in breast cancer

AM Fowler, DA Mankoff, BN Joe - Radiology, 2017 - pubs.rsna.org
The use of neoadjuvant systemic therapy in the treatment of breast cancer patients is
increasing beyond the scope of locally advanced disease. Imaging provides important …

Diffusion MRI of the breast: Current status and future directions

M Iima, M Honda, EE Sigmund… - Journal of Magnetic …, 2020 - Wiley Online Library
Diffusion‐weighted imaging (DWI) is increasingly being incorporated into routine breast MRI
protocols in many institutions worldwide, and there are abundant breast DWI indications …

Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study

Z Liu, Z Li, J Qu, R Zhang, X Zhou, L Li, K Sun… - Clinical Cancer …, 2019 - AACR
Purpose: We evaluated the performance of the newly proposed radiomics of multiparametric
MRI (RMM), developed and validated based on a multicenter dataset adopting a radiomic …

Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter …

YH Huang, T Zhu, XL Zhang, W Li, XX Zheng… - …, 2023 - thelancet.com
Background Accurate identification of pCR to neoadjuvant chemotherapy (NAC) is essential
for determining appropriate surgery strategy and guiding resection extent in breast cancer …

Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial

SC Partridge, Z Zhang, DC Newitt, JE Gibbs… - Radiology, 2018 - pubs.rsna.org
Purpose To determine if the change in tumor apparent diffusion coefficient (ADC) at diffusion-
weighted (DW) MRI is predictive of pathologic complete response (pCR) to neoadjuvant …

Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer

S Joo, ES Ko, S Kwon, E Jeon, H Jung, JY Kim… - Scientific reports, 2021 - nature.com
The achievement of the pathologic complete response (pCR) has been considered a metric
for the success of neoadjuvant chemotherapy (NAC) and a powerful surrogate indicator of …

Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy

ML Marinovich, N Houssami, P Macaskill… - Journal of the …, 2013 - academic.oup.com
Background It has been proposed that magnetic resonance imaging (MRI) be used to guide
breast cancer surgery by differentiating residual tumor from pathologic complete response …

Breast cancer: diffusion kurtosis MR imaging—diagnostic accuracy and correlation with clinical-pathologic factors

K Sun, X Chen, W Chai, X Fei, C Fu, X Yan, Y Zhan… - Radiology, 2015 - pubs.rsna.org
Purpose To assess diagnostic accuracy with diffusion kurtosis imaging (DKI) in patients with
breast lesions and to evaluate the potential association between DKI-derived parameters …

Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up

AA Malayeri, RH El Khouli, A Zaheer, MA Jacobs… - Radiographics, 2011 - pubs.rsna.org
Diffusion-weighted imaging relies on the detection of the random microscopic motion of free
water molecules known as Brownian movement. With the development of new magnetic …

Quantitative non-Gaussian diffusion and intravoxel incoherent motion magnetic resonance imaging: differentiation of malignant and benign breast lesions

M Iima, K Yano, M Kataoka, M Umehana… - Investigative …, 2015 - journals.lww.com
Objectives The purpose of this study was to explore the potential of non-Gaussian diffusion
and perfusion magnetic resonance imaging (MRI) using intravoxel incoherent motion (IVIM) …